Download Sample
Add to CartMagnetic Resonance imaging (MRI) Safe Neurostimulation Systems Market
By Product;
Implantable and TranscutaneousBy Application;
Sensory Nerve Stimulation, Spinal Cord Stimulation, Intracranial Stimulation, Deep Brain Stimulation, Motor Cortex Stimulation, Vagus Nerve Stimulation, and OthersBy End-Use;
Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)MRI Safe Neurostimulation Systems Market Overview
MRI Safe Neurostimulation Systems Market (USD Million)
MRI Safe Neurostimulation Systems Market was valued at USD 342.82 million in the year 2024. The size of this market is expected to increase to USD 966.84 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 16.0%.
Magnetic Resonance imaging (MRI) Safe Neurostimulation Systems Market
*Market size in USD million
CAGR 16.0 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 16.0 % |
| Market Size (2024) | USD 342.82 Million |
| Market Size (2031) | USD 966.84 Million |
| Market Concentration | Low |
| Report Pages | 300 |
Major Players
- AADCO Medical
- Biotronik
- Boston Scientific
- Codman & Shurtleffs
- Cyberonics
- Medtronic
- Neuronetics
- Nevro Corporation
- Sorin
- St. Jude Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Magnetic Resonance imaging (MRI) Safe Neurostimulation Systems Market
Fragmented - Highly competitive market without dominant players
Growing Demand for MRI-Safe Neurostimulation
The MRI Safe Neurostimulation Systems Market is expanding rapidly as the need for diagnostic imaging rises alongside implantable neurostimulation therapies. Nearly 65% of individuals with such implants require MRI scans, making MRI safety a critical product feature. This has led to a sharp uptick in demand for devices that function reliably in magnetic environments without compromising patient safety.
Technology Enhancements Accelerate Market Growth
Enhanced circuit protection, improved electrode design, and advanced system shielding are revolutionizing the functionality of MRI-safe neurostimulators. About 52% of devices entering development pipelines now carry MRI-compatible labels. These innovations are enabling uninterrupted treatment even when patients undergo essential imaging procedures.
Rise in Neurological Disorders Boosts Adoption
Chronic conditions like Parkinson’s, epilepsy, and neuropathic pain are increasing the use of neurostimulation systems. Around 47% of affected individuals are potential recipients of implants. With MRI access vital to ongoing care, the demand for MRI-safe systems continues to rise among clinicians and healthcare institutions.
Regulatory Pressures Push Product Design
Tighter safety regulations have pushed over 70% of device manufacturers to integrate MRI-safe compliance into their product design. These frameworks aim to enhance patient outcomes by ensuring diagnostic continuity and therapy reliability. MRI safety is now a core consideration in neuromodulation system development.
MRI Safe Neurostimulation Systems Market Recent Developments
-
In December 2023, Boston Scientific, a manufacturer of medical devices for interventional specialties, constructed a new manufacturing and supply chain facility in Johns Creek, Georgia. The $62.5 million investment created approximately 340 new jobs in Fulton County over the following seven years.
-
In January 2023, Nevro Corp., a global medical device company, announced a series of data presentations that supported the use of its HFX 10 kHz Therapy for patients with chronic pain, highlighting comprehensive, life-changing solutions for chronic pain treatment.
MRI Safe Neurostimulation Systems Market Segment Analysis
In this report, the MRI Safe Neurostimulation Systems Market has been segmented by Product, Application, End-Use and Geography.
MRI Safe Neurostimulation Systems Market, Segmentation by Product
The MRI Safe Neurostimulation Systems Market has been segmented by Product into Implantable and Transcutaneous.
Implantable
Implantable MRI safe neurostimulation systems are surgically placed devices designed for long-term management of conditions such as Parkinson’s disease, epilepsy, and chronic pain. These systems include electrodes and pulse generators that deliver targeted electrical impulses. Their ability to deliver continuous therapy and MRI compatibility makes them essential in chronic care treatment protocols.
Transcutaneous
Transcutaneous neurostimulation systems offer a non-invasive alternative by delivering electrical stimulation through the skin. These devices are commonly used for short-term relief in pain management, anxiety, and rehabilitation. Their portability and ease of home use have driven adoption in outpatient and home care settings, boosting demand in non-invasive neuromodulation.
MRI Safe Neurostimulation Systems Market, Segmentation by Application
The MRI Safe Neurostimulation Systems Market has been segmented by Application into Sensory Nerve Stimulation, Spinal Cord Stimulation, Intracranial Stimulation, Deep Brain Stimulation, Motor Cortex Stimulation, Vagus Nerve Stimulation and Others.
Sensory Nerve Stimulation
Sensory nerve stimulation is utilized to modulate pain signals by targeting sensory pathways, aiding in the treatment of chronic pain disorders. Its compatibility with MRI ensures uninterrupted diagnostic imaging. This application is gaining traction due to the rising prevalence of neuropathic pain syndromes and the demand for personalized pain relief strategies.
Spinal Cord Stimulation
Spinal cord stimulation (SCS) is extensively used for treating failed back surgery syndrome and complex regional pain syndrome. MRI-safe systems allow patients to undergo routine imaging without device removal, improving safety and convenience. Innovations in pulse modulation and programmability further strengthen this application’s market presence.
Intracranial Stimulation
Intracranial stimulation includes targeted brain interventions for conditions like epilepsy and movement disorders. With MRI compatibility, it ensures uninterrupted therapy and diagnostics. This segment benefits from growing research on neuromodulation’s impact on psychiatric and neurodegenerative conditions, widening its application scope across clinical settings.
Deep Brain Stimulation
Deep brain stimulation (DBS) involves implanting electrodes in specific brain areas to treat tremors, dystonia, and depression. MRI-safe DBS devices are vital for post-surgical imaging and therapy adjustment. The surge in neurological diseases and aging populations continues to drive this application globally.
Motor Cortex Stimulation
Motor cortex stimulation targets brain regions that govern voluntary movement, often used in patients with stroke-related deficits or chronic pain. The increasing clinical trials supporting its efficacy and the need for MRI compatibility make it a growing niche in the neuromodulation market.
Vagus Nerve Stimulation
Vagus nerve stimulation (VNS) is employed in the treatment of epilepsy and depression, using electrical impulses to regulate brain activity. As MRI scans are essential in long-term patient monitoring, MRI-safe VNS devices are crucial in neurological and psychiatric treatment protocols.
Others
This segment includes emerging applications such as sacral nerve and trigeminal nerve stimulation. The rise in studies targeting niche neuropsychiatric conditions, along with improvements in device safety and MRI compliance, is boosting adoption in specialized clinical practices and trials.
MRI Safe Neurostimulation Systems Market, Segmentation by End-Use
The MRI Safe Neurostimulation Systems Market has been segmented by End-Use into Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories and Others.
Hospitals
Hospitals account for the largest end-use segment due to their comprehensive neurology and radiology departments. These institutions utilize MRI safe neurostimulation systems in advanced pain management and neurodegenerative care. The need for simultaneous diagnostic imaging and treatment delivery drives system integration in tertiary and specialty care facilities.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) are increasingly using MRI-safe systems for outpatient neurostimulation procedures. The convenience of rapid recovery, reduced hospitalization costs, and efficient workflows make ASCs a growing market. Their rise reflects a shift toward minimally invasive and MRI-compatible medical interventions.
Diagnostic Laboratories
Diagnostic laboratories use these systems for clinical trials, research studies, and imaging integration. MRI-safe features enhance the accuracy of functional brain mapping and patient evaluations. These labs play a vital role in developing next-generation neurostimulation therapies through real-time imaging-guided protocols.
Others
This category includes rehabilitation centers, home healthcare, and specialized clinics. With the increase in chronic neurological disorders and demand for remote care, MRI-safe portable neurostimulation devices are gaining traction in non-hospital setups that emphasize mobility and patient-centered care.
MRI Safe Neurostimulation Systems Market, Segmentation by Geography
The MRI Safe Neurostimulation Systems Market has been segmented by Geography into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
MRI Safe Neurostimulation Systems Market Share (%), by Geographical Region
North America
North America dominates the market with a share of 38.6%, supported by high healthcare expenditure, rapid technology adoption, and an aging population. The U.S. leads in neurostimulation R&D and adoption, while regulatory frameworks support the integration of MRI-compatible devices in clinical practices and hospitals.
Europe
Europe holds a 27.4% share, driven by established medical infrastructure and demand for advanced diagnostics. Countries like Germany, the UK, and France are prominent adopters, supported by favorable reimbursement systems and extensive use of neuroimaging-based therapies in chronic pain and neurology.
Asia Pacific
Asia Pacific accounts for 21.8% of the market, with fast-growing healthcare investments in China, India, and Japan. Rising awareness, aging populations, and expanding medical device industries are enhancing access to MRI-safe neuromodulation therapies across both urban and rural healthcare systems.
Middle East and Africa
The Middle East and Africa region contributes 6.1% of the global share, driven by increasing investments in modernizing healthcare infrastructure. MRI-safe systems are being integrated in leading hospitals and neurology clinics, particularly in countries like Saudi Arabia and South Africa.
Latin America
Latin America represents 6.1% of the global market, with Brazil and Mexico at the forefront of neurostimulation adoption. Growth is supported by public-private partnerships, expansion of diagnostic imaging services, and increasing demand for non-invasive neurological therapies.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global MRI Safe Neurostimulation Systems Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Advancements in Neurostimulation Technology
- Rising Prevalence of Neurological Disorders
- Increasing Demand for Minimally Invasive Procedures
- Growing Aging Population:
The growing aging population worldwide is a significant demographic trend that is shaping various sectors, including healthcare and medical device markets such as the Global MRI Safe Neurostimulation Systems Market. As populations age, there is an inevitable increase in the prevalence of age-related conditions and chronic diseases, driving the demand for advanced medical technologies that can cater to the unique healthcare needs of elderly individuals.
One of the key drivers attributed to the aging population is the rising incidence of neurological disorders and chronic pain conditions among older adults. Neurostimulation systems offer promising therapeutic benefits for managing chronic pain, movement disorders, and other neurological conditions that become more prevalent with age. The demand for MRI-safe neurostimulation systems is particularly critical as elderly patients often require diagnostic imaging procedures such as MRI scans for comprehensive medical evaluations. Ensuring compatibility with MRI technology allows healthcare providers to offer integrated care solutions without compromising diagnostic accuracy or patient safety.
Restraints
- High Cost of MRI-Safe Neurostimulation Systems
- Regulatory Challenges and Compliance Requirements
- Limited Awareness and Access in Developing Regions
-
Potential Risks and Safety Concerns:Potential risks and safety concerns associated with MRI-safe neurostimulation systems are critical considerations in the development, deployment, and adoption of these advanced medical devices. While these systems offer significant therapeutic benefits, ensuring patient safety and minimizing risks are paramount to their successful integration into clinical practice.One of the primary safety concerns revolves around the compatibility of neurostimulation devices with MRI technology. MRI scanners generate powerful magnetic fields and radiofrequency pulses, which can interact with implanted devices and potentially lead to device malfunction, heating, or displacement. Ensuring MRI compatibility requires rigorous testing and validation processes during device design and regulatory approval stages. Manufacturers must adhere to strict guidelines and standards to mitigate these risks and ensure that neurostimulation systems maintain functionality and safety during MRI procedures.
Another critical safety consideration is the potential for adverse effects or complications associated with long-term implantation of neurostimulation devices. Common risks include infection at the implantation site, lead migration or fracture, nerve damage, and unintended stimulation effects. Healthcare providers must carefully evaluate patient candidacy, assess individual risk factors, and provide comprehensive patient education and monitoring protocols to mitigate these risks effectively. Regular follow-up visits and device interrogation are essential to monitor device performance, optimize therapy settings, and promptly address any emerging safety concerns or adverse events.
Opportunities
- Expansion in Emerging Markets
- Technological Innovations in MRI Compatibility
- Collaborations and Partnerships with Healthcare Providers
-
Integration with AI and Machine Learning:The integration of MRI-safe neurostimulation systems with artificial intelligence (AI) and machine learning (ML) represents a transformative trend poised to revolutionize the landscape of neurological therapies. AI and ML technologies offer advanced capabilities in data analytics, pattern recognition, and predictive modeling, which can significantly enhance the effectiveness and precision of neurostimulation treatments.AI and ML algorithms can optimize the programming and customization of neurostimulation therapies based on individual patient responses and real-time physiological data. By analyzing large datasets of patient outcomes, AI algorithms can identify patterns and correlations that facilitate personalized treatment adjustments, leading to improved therapeutic outcomes and patient satisfaction. This capability is particularly beneficial in optimizing stimulation parameters, adapting therapy settings over time, and predicting patient responses to specific neurostimulation protocols.
AI-powered analytics can enable remote monitoring and management of MRI-safe neurostimulation systems, enhancing healthcare delivery and patient care coordination. Real-time data analysis can alert healthcare providers to potential issues such as device malfunction or patient non-compliance, enabling proactive interventions and timely adjustments to treatment plans. Additionally, AI algorithms can contribute to predictive maintenance strategies, optimizing device longevity and reducing the likelihood of unplanned device replacements or patient discomfort.
Competitive Landscape Analysis
Key players in Global MRI Safe Neurostimulation Systems Market include:
- AADCO Medical
- Biotronik
- Boston Scientific
- Codman & Shurtleffs
- Cyberonics
- Medtronic
- Neuronetics
- Nevro Corporation
- Sorin
- St. Jude Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- MRI Safe Neurostimulation Systems Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in Neurostimulation Technology
- Rising Prevalence of Neurological Disorders
- Increasing Demand for Minimally Invasive Procedures
- Growing Aging Population
- Restraints
- High Cost of MRI-Safe Neurostimulation Systems
- Regulatory Challenges and Compliance Requirements
- Limited Awareness and Access in Developing Regions
- Potential Risks and Safety Concerns
- Opportunities
- Expansion in Emerging Markets
- Technological Innovations in MRI Compatibility
- Collaborations and Partnerships with Healthcare Providers
- Integration with AI and Machine Learning
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- MRI Safe Neurostimulation Systems Market, By Product, 2021 - 2031 (USD Million)
- Implantable
- Transcutaneous
- MRI Safe Neurostimulation Systems Market, By Application, 2021 - 2031 (USD Million)
- Sensory Nerve Stimulation
- Spinal Cord Stimulation
- Intracranial Stimulation
- Deep Brain Stimulation
- Motor Cortex Stimulation
- Vagus Nerve Stimulation
- Others
- MRI Safe Neurostimulation Systems Market, By End-Use, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
-
Research Laboratories
- Others
- MRI Safe Neurostimulation Systems Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- MRI Safe Neurostimulation Systems Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- AADCO Medical
- Biotronik
- Boston Scientific
- Codman & Shurtleffs
- Cyberonics
- Medtronic
- Neuronetics
- Nevro Corporation
- Sorin
- St. Jude Medical
- Company Profiles
- Analyst Views
- Future Outlook of the Market